6550--NEW - STX Core Lab QC Consumables
Veterans Affairs · 257-NETWORK CONTRACT OFFICE 17 (36C257)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 36C25726Q0381 in this department, oldest first.
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Decide bid or no bid before the response deadline.
- Look at the past winners for likely competitors and teaming partners.
- Follow the opportunity to hear about amendments and the award.
What the notice says
Purpose of Amendment The purpose of this amendment is to extend the submission due date and time for Solicitation 36C25726Q0381 to allow additional time for the preparation and submission of quotations. Change to Solicitation The solicitation is hereby amended as follows: The quotation submission due date and time is extended from May 8, 2026, at 10:00 AM Central Time � To: May 13, 2026, at 10:00 AM Central Time All references in the solicitation to the quotation due date and time shall be deemed to reflect the new due date and time stated above. No Other Changes Except as specifically provide… (show all)
d herein, all terms, conditions, specifications, and provisions of the solicitation remain unchanged and in full force and effect. Acknowledgment of Amendment Offerors shall acknowledge receipt of this amendment in accordance with the instructions in the solicitation. Failure to acknowledge may result in the offeror being found nonresponsive.
Who won similar work
12 award notices on SAM.gov in the last 24 months. Matched by: Same office (257-NETWORK CONTRACT OFFICE 17 (36C257)), same product/service code (PSC) 6550 and NAICS 325413.
Single-winner award sizes (12): middle half $392K to $1.5M, median $857K; range $107K to $6.3M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| CEPHEID SUNNYVALE 94089 | 3 | $8.4M | Apr 2, 2026 |
| BECTON, DICKINSON AND COMPANY · $BDX · $19.4B | 2 | $2.1M | Apr 27, 2026 |
| ROCHE DIAGNOSTICS CORPORATION | 2 | $1.5M | Aug 28, 2026 |
| BIOMERIEUX INC | 1 | $2.0M | Aug 6, 2025 |
| VETERANS HEALTHCARE SUPPLY SOLUTIONS, INC | 1 | $1.0M | Aug 4, 2025 |
| BECKMAN COULTER, INC | 1 | $406K | Mar 19, 2025 |
| HOLOGIC SALES AND SERVICE, LLC | 1 | $350K | Oct 2, 2025 |
| GOVERNMENT SCIENTIFIC SOURCE INC | 1 | $176K | Oct 29, 2024 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- $BDX reported $19.4B revenue in FY2025. The median single-winner award in these 12 past awards, $857K, is under 0.1% of that. 10-K
One award's total value against one year of revenue; many awards are paid over several years.
- Aug 28, 2026ROCHE DIAGNOSTICS CORPORATION$107K6550--Glucose Accu-Chek® Test StripsNo listed company matched (Materiality N/A)
- Apr 27, 2026BECTON, DICKINSON AND COMPANY$1.6M6550--NEW - STX Flow Cytometry Rgts/ConsumablesMateriality: <0.01% of $BDX revenue (Low) SEC
- Apr 22, 2026ROCHE DIAGNOSTICS CORPORATION$1.4M6550--NTX Ventana ReagentsNo listed company matched (Materiality N/A)
- Apr 2, 2026CEPHEID SUNNYVALE 94089$714K6550--STX Cepheid Reagents - Ordering Period 1No listed company matched (Materiality N/A)
- Dec 29, 2025CEPHEID SUNNYVALE 94089$6.3M6550--NEW - Cepheid Reagents ContractNo listed company matched (Materiality N/A)
- Oct 2, 2025HOLOGIC SALES AND SERVICE, LLC$350K6550--NEW - Hologic Reagents (Cytology) IDIQNo listed company matched (Materiality N/A)
- Aug 6, 2025BIOMERIEUX INC$2.0M6550-- NTX BioFire Torch IDIQNo listed company matched (Materiality N/A)
- Aug 4, 2025VETERANS HEALTHCARE SUPPLY SOLUTIONS, INC$1.0M6550-- CTX ABL 90 Reagents and ConsumablesNo listed company matched (Materiality N/A)
- Mar 31, 2025BECTON, DICKINSON AND COMPANY$543K6550--South Texas VA COVID BD Flow Reagents Ordering Period 4Materiality: <0.01% of $BDX revenue (Low) SEC
- Mar 19, 2025BECKMAN COULTER, INC$406K6550--Urinalysis Analyzer Cost-Per-Reportable-Result (CPRR)No listed company matched (Materiality N/A)
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 1 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (6 filings)
- 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- $25K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Veterans' Affairs, Senate Committee on Appropriations, Senate Committee on Veterans' Affairs
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 1 of the past winners are listed companies
- 0 insider buys and 4 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.